|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SUl1248 in acute myeloid leukemia patients显示文摘 | O'Farrell AM Foran JM Fiedler W | 2003 | Clin Cancer Res2003，9，15： | 1 |
| 2 | Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes 显示文摘 | Foran JM Shammo JM | 2012 | Am J Med2012，125，7： | 1 |
| 3 | Guidelines for quality assurance of drug information centres-The society of hospital pharmacists of Australia committee of specialty practice in drug information 显示文摘 | Thomson B Foran SM | 1993 | Aust J Hosp Pharm1993，23，4： | 1 |
| 4 | New prognostic markers in acute myeloid leukemiai perspective from the clinic显示文摘 | Foran JM | 2010 | Hematology Am Soc Hematol Educ Program2010，2010，： | 1 |
| 5 | Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with low-grade non- Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia显示文摘 | Foran JM Oscier D Orchard J | 1999 | J Clin Oncol1999，17，5： | 1 |
| 6 | New prognostic markers in acute myeloid leukemia:per spective from the clinic显示文摘 | Foran JM | | 0，，： | 1 |
| 7 | European phase Ⅱ study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma,immunocytoma,and small B-cell lymphocytic lymphoma显示文摘 | Rohatiner AZS Cunningham D | 2000 | J Clin Oncol2000，18，： | 1 |
| 8 | An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients显示文摘 | O'FARRELL AM FORAN JM FIEDLER W | 2003 | Clin Cancer Res2003，9，15： | 1 |
| 9 | A phase 1 study of quizartinib administated daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FLT3-ITD status显示文摘 | Cortes J Kantarjian H Foran JM | 2013 | J Clin Oncol2013，31，29： | 1 |
| 10 | Phase I study of quizar- tinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status 显示文摘 | Cortes JE Kantarjian H Foran JM | 2013 | J Clin Oncol2013，31，29： | 1 |
| 11 | Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macro globulinemia, and mantle-cell lymphoma显示文摘 | Foran JM Rohatiner AZ Coiffier B | 1999 | J Clin Oncol1999，17，2： | 1 |
| 12 | Immunocytoma: a retrospective analysis from St Bartholomew's Hospital-1972 to 1996显示文摘 | Papamichael D Norton AJ Foran JM | 1999 | J Clin Oncol1999，17，9： | 1 |
| 13 | European phase Ⅱ study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lym phoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma显示文摘 | Foran JM Rohatiner AZ Cunningham D | 2000 | J Clin Oncol2000，18，2： | 1 |
| 14 | An innovative phase Ⅰ clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients 显示文摘 | O'FARRELL AM FORAN JM FIEDLER W | 2003 | Clin Cancer Res2003，9，15： | 1 |
| 15 | Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status显示文摘 | Cortes JE Kantarjian H Foran JM | 2013 | J Clin Onco12013，31，29： | 1 |
| 16 | European phase Ⅱ study of rituximab (chimeric anti-CD20 monoclonal antibody)for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma显示文摘 | Foran JM Rohatiner AZ Cunningham D | 2000 | J Clin Oncol2000，18，2： | 1 |
| 17 | Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti- CD20): a retrospective cohort analysis显示文摘 | Foran JM Norton AJ Micallef IN | 2001 | Br J Haematol2001，114，4： | 1 |
| 18 | European phase Ⅱ study of rituximah (chimeric anti-CD20 monoclonal antibody )for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma显示文摘 | Foran JM Rohatiner AZS Cunningham D | 2000 | J Clin Oncol2000，18，： | 1 |
| 19 | High-dose chemotherapy for follicular low-grade non-Hodgkin's lymphoma显示文摘 | Foran JM Rohatiner AZS Norton AJ | 1997 | Proc Am Soc Clin Oncol1997，16，： | 1 |
| 20 | Multicenter phase Ⅱ study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma,Waldenstrom's macroglobulinemia, and mantle-cell lymphoma显示文摘 | Foran JM Rohatiner AZ Coiffier B | 1999 | J Clin Oncol1999，17，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员